NKF(SH:603707) Shang Hai Zheng Quan Bao·2025-06-27 20:31Group 1 - The core viewpoint of the announcement is that the credit rating for Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.'s convertible bonds remains unchanged at "AA" with a stable outlook [2][3]. - The previous rating for "Jianyou Convertible Bonds" was also "AA" with a stable outlook, indicating consistency in the company's creditworthiness [3]. - The tracking credit rating was conducted by United Credit Rating Co., Ltd., which assessed the company's business, management, and financial situation before issuing the report on June 27, 2025 [3]. Group 2 - The announcement confirms that the company's credit rating and the rating for the convertible bonds have not changed since the last assessment on June 26, 2024 [2][3]. - The report is available for further details on the Shanghai Stock Exchange website [3]. - The announcement was officially made by the board of directors of Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. on June 28, 2025 [5].